November 1, 2026

News, minutes after it breaks

Technology
Latest
Ukrainian evacuees from Russian-occupied Oleshky reunite with familyWhat we know about latest efforts to end US war on IranIndia’s largest dam planned to counter China faces Indigenous revoltThe murder of Javits Frimpong, a bullied schoolboy in The BronxTrump grants visa to mother of Ghanaian boy killed in NYC — MamdaniFBI blames North Korea for record $6.3bn crypto heist from BinanceThousands rally in Israel urging ‘Jewish-Arab’ coalition to oust NetanyahuShops looted as German cost of living protests turn violentUkrainian evacuees from Russian-occupied Oleshky reunite with familyWhat we know about latest efforts to end US war on IranIndia’s largest dam planned to counter China faces Indigenous revoltThe murder of Javits Frimpong, a bullied schoolboy in The BronxTrump grants visa to mother of Ghanaian boy killed in NYC — MamdaniFBI blames North Korea for record $6.3bn crypto heist from BinanceThousands rally in Israel urging ‘Jewish-Arab’ coalition to oust NetanyahuShops looted as German cost of living protests turn violent

Home  / Technology

The FDA wants to pull its approval of a drug. It’s not so easy.

Technology Ars Technica
Image: Ars Technica

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

Ars Technica reported this story. Read the full report on arstechnica.com →

This is a short summary. Ars Technica wrote and published the full report.

Continue on arstechnica.com →

More in Technology

Leave a Reply

Your email address will not be published. Required fields are marked *